AbnomX
AbnomX develops software platforms for antibody sequence and immune repertoire analysis to accelerate antibody discovery.
AbnomX offers the Antibody-Extractor platform, a software with algorithms dedicated to antibody sequence and repertoire analysis that accelerates phage-display and NGS-based antibody discovery. The company also provides an API for bioinformaticians and developers, and is developing TCR-Profiler for TCR sequence analysis.
Key People
Khalil El Mazouari - Founder, CEO